Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.85 USD | +0.38% | -2.33% | -14.02% |
Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Apr. 09 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Financials (USD)
Sales 2024 * | 1.52B | Sales 2025 * | 1.53B | Capitalization | 4.04B |
---|---|---|---|---|---|
Net income 2024 * | 352M | Net income 2025 * | 331M | EV / Sales 2024 * | 2.14 x |
Net cash position 2024 * | 791M | Net cash position 2025 * | 1.17B | EV / Sales 2025 * | 1.88 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
12.9
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.59% |
Latest transcript on Alkermes plc
1 day | +0.38% | ||
1 week | -2.33% | ||
Current month | -11.90% | ||
1 month | -13.90% | ||
3 months | -14.52% | ||
6 months | -11.04% | ||
Current year | -14.02% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 98-12-31 |
Shane Cooke
PSD | President | 61 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 16-05-25 |
Brian McKeon
BRD | Director/Board Member | 61 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 215 M€ | +13.63% | - | |
2.65% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 23.85 | +0.38% | 2,414,813 |
24-04-18 | 23.76 | -1.04% | 1,798,839 |
24-04-17 | 24.01 | +1.01% | 2,257,028 |
24-04-16 | 23.77 | -1.04% | 1,579,931 |
24-04-15 | 24.02 | -1.64% | 2,713,260 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.02% | 4.02B | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- ALKS Stock